Fuzapladib

Overview

Fuzapladib (IS-741), an orally active leukocyte-function-associated antigen type 1 (LFA-1) activation inhibitor, is a leukocyte adhesion molecule. Fuzapladib is also a phospholipase A2 (PLA2) inhibitor. Fuzapladib exerts anti-inflammatory effects by inhibiting leukocyte migration into the inflammatory site.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Cytoskeleton | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Integrin | Products > Signaling Pathways > Phospholipase

Product Information

• Catalog No.: HY-19151
• CAS No.: 141283-87-6
• Molecular Formula: C15H20F3N3O3S
• Molecular Weight: 379.40
• Purity: 98.75%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 2.5 mg/mL (6.59 mM); Clear solution
• Availability: In-stock

Source

Original product source